Description

CarbaMic acid, N-[(1S,3S)-3-[4-Methoxy-3-(3-Methoxypropoxy)benzoyl]-4-Methyl-1-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-diMethylethyl ester is a high-purity, complex chiral intermediate of significant importance in advanced pharmaceutical synthesis. This compound matters because it serves as a critical building block for the development of novel therapeutic agents, particularly in complex molecule construction. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities (NCEs) and active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key chiral synthon in the multi-step synthesis of complex, biologically active molecules and potential APIs.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Chemistry: Serves as a critical intermediate in scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Asymmetric Synthesis: Utilized in reactions requiring high stereochemical control due to its defined chiral centers.
• Custom Synthesis: A starting material for contract research organizations (CROs) and CDMOs producing specialized compounds for clients.

Basic Information

Product Name	CarbaMic acid, N-[(1S,3S)-3-[4-Methoxy-3-(3-Methoxypropoxy)benzoyl]-4-Methyl-1-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]pentyl]-, 1,1-diMethylethyl ester
CAS No.	934841-22-2
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	tert-Butyl (2S,4S)-4-[(2S)-2-[(1S,3S)-3-[4-Methoxy-3-(3-methoxypropoxy)benzoyl]-4-methylpentanamido]-4-methylpentanoyl]-5-oxo-2-(propan-2-yl)oxolane-2-carboxylate; (2S,4S)-1-[(2S)-2-[(1S,3S)-3-[4-Methoxy-3-(3-methoxypropoxy)benzoyl]-4-methylpentanamido]-4-methylpentanoyl]-5-oxo-2-(propan-2-yl)oxolane-2-carboxylic acid tert-butyl ester; CAS 934841-22-2; Carbamic acid derivative intermediate; Complex chiral ester intermediate.
EINECS	Contact for details

Quality Control

Our CarbaMic acid intermediate is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity and impurity profile analysis, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data (HPLC, chiral HPLC) are provided for full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed in a desiccated environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.